ARK Innovation ETF (ARKK) Daily Position Changes Report: April 24 to April 27, 2026
Overview
Between April 24 and April 27, 2026, the ARK Innovation ETF (ARKK) actively adjusted its portfolio with both significant buys and sells. Total estimated buy trades amounted to approximately $345,154,129.30, while total estimated sell trades reached about $15,769,737.12. Key additions to the portfolio included Advanced Micro Devices Inc (AMD) and Tesla Inc (TSLA), reflecting continued confidence in high-growth technology sectors. Conversely, the fund modestly trimmed positions in CRISPR Therapeutics AG (CRSP) and Beam Therapeutics Inc (BEAM), likely as part of portfolio rebalancing.
Analysis and Interpretation
ARKK's trading activity during this period highlights a strategic emphasis on strengthening positions in semiconductor and technology companies, notably AMD and TSLA, potentially signaling confidence in innovation-driven growth prospects in these sectors. The reduction in holdings of CRSP and BEAM indicates a possible shift away from certain biotechnologies or an attempt to manage exposure and risk. Overall, the trading pattern suggests ARK Invest is recalibrating its portfolio to focus more intensively on companies with imminent technological advancements and market leadership, aligning with its thematic investment approach centered on disruptive innovation.
Position Changes Table
| Ticker | Company Name | Direction | Shares Traded | Estimated Trade Value ($) | % of Portfolio Change |
|---|---|---|---|---|---|
| TSLA | Tesla Inc | Buy | N/A | $72,096,430.67 | 0.0769% |
| AMD | Advanced Micro Devices Inc | Buy | N/A | $110,088,931.71 | 0.9363% |
| CRSP | CRISPR Therapeutics AG | Sell | N/A | -$7,991,907.76 | -0.6414% |
| TEM | Tempus AI Inc-A | Buy | N/A | $25,339,783.64 | -0.1284% |
| SHOP | Shopify Inc-A | Buy | N/A | $28,099,944.51 | -0.0454% |
| COIN | Coinbase Global Inc-A | Buy | N/A | $33,013,241.40 | 0.0251% |
| HOOD | Robinhood Markets Inc-A | Buy | N/A | $17,023,043.51 | -0.1811% |
| ROKU | Roku Inc-A | Buy | N/A | $32,985,654.56 | 0.0456% |
| CRCL | None | Buy | N/A | $26,507,099.30 | -0.0359% |
| BEAM | Beam Therapeutics Inc | Sell | N/A | -$7,777,829.36 | -0.4249% |
Explore more exclusive insights at nextfin.ai.
